# Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers

> **NCT02619877** · PHASE2 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 59 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **BIOLOGICAL:** ALLO-ASC-DFU
- **OTHER:** Standard therapy

## Key facts

- **NCT ID:** NCT02619877
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-10
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2017-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02619877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02619877, "Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02619877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*